COVID-19 and influenza vaccine-hesitancy subgroups

Otto Mäki; Linda Karlsson; Johanna K. Kaakinen; Philipp Schmid; Stephan Lewandowsky; Jan Antfolk; Anna Soveri

doi:10.1371/journal.pone.0308159

COVID-19 and influenza vaccine-hesitancy subgroups

Otto Mäki^*
, Linda Karlsson
, Johanna K. Kaakinen
, Philipp Schmid
, Stephan Lewandowsky
, Jan Antfolk
, Anna Soveri

^*Korresponderande författare för detta arbete

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

11 Citeringar (Scopus)

76 Nedladdningar (Pure)

Sammanfattning

Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis) similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.

Originalspråk	Engelska
Artikelnummer	e0308159
Tidskrift	PLoS ONE
Volym	19
Nummer	7 July
DOI	https://doi.org/10.1371/journal.pone.0308159
Status	Publicerad - juli 2024
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Finansiering

This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 964728 (JITSUVAX). KOM was funded by the Faculty of Social Sciences at the University of Turku (www.utu.fi/en/university/faculty-of-socialsciences). JKK and KOM received funding from the Strategic Research Council's LITERACY program (Research Council of Finland grant number: 335233). JKK received funding from the Strategic Research Council's Fostering Finnish Science Capital project (FINSCI; grant number: 358271). AS was funded by the Academy of Finland (grant number: 316004; www.aka.fi/en/). SL also acknowledges funding from the Humboldt Foundation Germany through a research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Åtkomst av dokument

10.1371/journal.pone.0308159Licens: CC BY

journal.pone.0308159Slutlig publicerad version, 1,21 MBLicens: CC BY

https://urn.fi/URN:NBN:fi-fe20241216102792

Citera det här

@article{7379f60242a248d5b5a29f6c3eb70083,

title = "COVID-19 and influenza vaccine-hesitancy subgroups",

abstract = "Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis) similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.",

author = "Otto M{\"a}ki and Linda Karlsson and Kaakinen, \{Johanna K.\} and Philipp Schmid and Stephan Lewandowsky and Jan Antfolk and Anna Soveri",

year = "2024",

month = jul,

doi = "10.1371/journal.pone.0308159",

language = "English",

volume = "19",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "7 July",

}

TY - JOUR

T1 - COVID-19 and influenza vaccine-hesitancy subgroups

AU - Mäki, Otto

AU - Karlsson, Linda

AU - Kaakinen, Johanna K.

AU - Schmid, Philipp

AU - Lewandowsky, Stephan

AU - Antfolk, Jan

AU - Soveri, Anna

PY - 2024/7

Y1 - 2024/7

N2 - Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis) similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.

AB - Health communicators are faced with the challenge that people can hesitate vaccines for different reasons. Our aim was to identify and describe the qualities of distinct COVID-19 and influenza vaccine-hesitancy subgroups to facilitate the development of tailored vaccine-hesitancy communication. In two studies, we used agglomerative hierarchical cluster analysis to identify COVID-19 (N = 554) and influenza (N = 539) vaccine-hesitancy subgroups in the general population based on nine vaccine hesitancy-related variables (intent to get vaccinated, perceived vaccine safety, perceived vaccine efficacy, perceived disease threat, perceived vaccination responsibility, perceived vaccination convenience, distrust in authorities, conspiracy mentality, and reliance on anecdotal testimonies). We identified and described six distinct COVID-19 vaccine-hesitancy subgroups (the Vaccination Positive, the Ambivalent, the Fearing Skeptic, the Unconvinced, the Constrained Skeptic, and the Vaccination Opponent), and three influenza vaccine-hesitancy subgroups (the Vaccination Positive, the Complacent, and the Vaccination Opponent), with different levels of hesitancy. We discuss the implications of the results for health communicators. Our results shed light on the (dis) similarities between people who hesitate COVID-19 and influenza vaccines and suggest that there is greater variety in hesitancy concerning COVID-19 vaccinations than influenza vaccinations. These findings can be used to design and test tailored vaccination messages.

U2 - 10.1371/journal.pone.0308159

DO - 10.1371/journal.pone.0308159

M3 - Article

SN - 1932-6203

VL - 19

JO - PLoS ONE

JF - PLoS ONE

IS - 7 July

M1 - e0308159

ER -

COVID-19 and influenza vaccine-hesitancy subgroups

Sammanfattning

Finansiering

Åtkomst av dokument

Fingeravtryck

Citera det här